Subcutaneous Immunoglobulin (SCig) for Maintenance Therapy in Severe POTS: A Case Report.

Authors

  • Tahrima Ferdous University of Toledo

DOI:

https://doi.org/10.46570/utjms.vol11-2023-938

References

Sheldon RS, Grubb BP II, Olshansky B, Shen WK, Calkins H, Brignole M et al (2015) 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. 2015 Jun;12(6):e41-63. doi: 10.1016/j.hrthm.2015.03.029. Epub 2015 May 14.

Ballow M. Safety of IGIV therapy and infusion-related adverse events. Immunol Res. 2007;38(1-3):122-32. doi: 10.1007/s12026-007-0003-5. PMID: 17917017.

Mohammed Ruzieh, Lillian Batizy, Osama Dasa, Carson Oostra & Blair Grubb (2017) The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review, Scandinavian Cardiovascular Journal, 51:5, 243-247, DOI: 10.1080/14017431.2017.1355068

Downloads

Published

2023-12-15

How to Cite

Ferdous, T. (2023). Subcutaneous Immunoglobulin (SCig) for Maintenance Therapy in Severe POTS: A Case Report. Translation: The University of Toledo Journal of Medical Sciences, 11(3). https://doi.org/10.46570/utjms.vol11-2023-938

Issue

Section

Dr. Lance D. Dworkin Department of Medicine Research Symposium